These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 22359669)
1. Activation of a helper and not regulatory human CD4+ T cell response by oncolytic H-1 parvovirus. Moralès O; Richard A; Martin N; Mrizak D; Sénéchal M; Miroux C; Pancré V; Rommelaere J; Caillet-Fauquet P; de Launoit Y; Delhem N PLoS One; 2012; 7(2):e32197. PubMed ID: 22359669 [TBL] [Abstract][Full Text] [Related]
2. A rapid flow cytometric assay to detect CD4+ and CD8+ T-helper (Th) 0, Th1 and Th2 cells in whole blood and its application to study cytokine levels in atopic dermatitis before and after cyclosporin therapy. Farrell AM; Antrobus P; Simpson D; Powell S; Chapel HM; Ferry BL Br J Dermatol; 2001 Jan; 144(1):24-33. PubMed ID: 11167679 [TBL] [Abstract][Full Text] [Related]
3. Immune cells participate in the oncosuppressive activity of parvovirus H-1PV and are activated as a result of their abortive infection with this agent. Grekova S; Aprahamian M; Giese N; Schmitt S; Giese T; Falk CS; Daeffler L; Cziepluch C; Rommelaere J; Raykov Z Cancer Biol Ther; 2010 Dec; 10(12):1280-9. PubMed ID: 21124075 [TBL] [Abstract][Full Text] [Related]
4. NK-cell-dependent killing of colon carcinoma cells is mediated by natural cytotoxicity receptors (NCRs) and stimulated by parvovirus infection of target cells. Bhat R; Rommelaere J BMC Cancer; 2013 Jul; 13():367. PubMed ID: 23902851 [TBL] [Abstract][Full Text] [Related]
5. Combined oncolytic and vaccination activities of parvovirus H-1 in a metastatic tumor model. Raykov Z; Grekova S; Galabov AS; Balboni G; Koch U; Aprahamian M; Rommelaere J Oncol Rep; 2007 Jun; 17(6):1493-9. PubMed ID: 17487410 [TBL] [Abstract][Full Text] [Related]
7. Immune response is an important aspect of the antitumor effect produced by a CD40L-encoding oncolytic adenovirus. Diaconu I; Cerullo V; Hirvinen ML; Escutenaire S; Ugolini M; Pesonen SK; Bramante S; Parviainen S; Kanerva A; Loskog AS; Eliopoulos AG; Pesonen S; Hemminki A Cancer Res; 2012 May; 72(9):2327-38. PubMed ID: 22396493 [TBL] [Abstract][Full Text] [Related]
8. A role for CD4+ NK1.1+ T lymphocytes as major histocompatibility complex class II independent helper cells in the generation of CD8+ effector function against intracellular infection. Denkers EY; Scharton-Kersten T; Barbieri S; Caspar P; Sher A J Exp Med; 1996 Jul; 184(1):131-9. PubMed ID: 8691126 [TBL] [Abstract][Full Text] [Related]
9. Activation of the human immune system via toll-like receptors by the oncolytic parvovirus H-1. Sieben M; Schäfer P; Dinsart C; Galle PR; Moehler M Int J Cancer; 2013 Jun; 132(11):2548-56. PubMed ID: 23151948 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of NK cell antitumor responses using an oncolytic parvovirus. Bhat R; Dempe S; Dinsart C; Rommelaere J Int J Cancer; 2011 Feb; 128(4):908-19. PubMed ID: 20473905 [TBL] [Abstract][Full Text] [Related]
11. Parvovirus H-1 induces cytopathic effects in breast carcinoma-derived cultures. Muharram G; Le Rhun E; Loison I; Wizla P; Richard A; Martin N; Roussel A; Begue A; Devos P; Baranzelli MC; Bonneterre J; Caillet-Fauquet P; Stehelin D Breast Cancer Res Treat; 2010 May; 121(1):23-33. PubMed ID: 19565332 [TBL] [Abstract][Full Text] [Related]
12. CD4+ T cell clones isolated from human renal cell carcinoma possess the functional characteristics of Th2 helper cells. Schoof DD; Terashima Y; Peoples GE; Goedegebuure PS; Andrews JV; Richie JP; Eberlein TJ Cell Immunol; 1993 Aug; 150(1):114-23. PubMed ID: 8102084 [TBL] [Abstract][Full Text] [Related]
13. Cytotoxic T lymphocyte-associated protein 4 antibody aggrandizes antitumor immune response of oncolytic virus M1 via targeting regulatory T cells. Liu W; Liu Y; Hu C; Xu C; Chen J; Chen Y; Cai J; Yan G; Zhu W Int J Cancer; 2021 Sep; 149(6):1369-1384. PubMed ID: 34086978 [TBL] [Abstract][Full Text] [Related]
14. Immune Conversion of Tumor Microenvironment by Oncolytic Viruses: The Protoparvovirus H-1PV Case Study. Marchini A; Daeffler L; Pozdeev VI; Angelova A; Rommelaere J Front Immunol; 2019; 10():1848. PubMed ID: 31440242 [TBL] [Abstract][Full Text] [Related]
15. Diversion of CD4+ T cell development from regulatory T helper to effector T helper cells alters the contact hypersensitivity response. DiIulio NA; Xu H; Fairchild RL Eur J Immunol; 1996 Nov; 26(11):2606-12. PubMed ID: 8921946 [TBL] [Abstract][Full Text] [Related]
16. Intratumoral expression of interleukin 23 variants using oncolytic vaccinia virus elicit potent antitumor effects on multiple tumor models via tumor microenvironment modulation. Chen L; Chen H; Ye J; Ge Y; Wang H; Dai E; Ren J; Liu W; Ma C; Ju S; Guo ZS; Liu Z; Bartlett DL Theranostics; 2021; 11(14):6668-6681. PubMed ID: 34093846 [No Abstract] [Full Text] [Related]
17. Human Retrotransposons and the Global Shutdown of Homeostatic Innate Immunity by Oncolytic Parvovirus H-1PV in Pancreatic Cancer. Neulinger-Muñoz M; Schaack D; Grekova SP; Bauer AS; Giese T; Salg GA; Espinet E; Leuchs B; Heller A; Nüesch JPF; Schenk M; Volkmar M; Giese NA Viruses; 2021 May; 13(6):. PubMed ID: 34071585 [TBL] [Abstract][Full Text] [Related]
18. CD8+ suppressor cells inhibit staphylococcal protein A-induced gamma interferon production by CD4+ lymphocytes. Kasparian SS; Menezes J Immunol Lett; 1991 Jan; 27(1):31-7. PubMed ID: 1673445 [TBL] [Abstract][Full Text] [Related]
19. Aetiopathogenesis of autoimmune hepatitis. Vergani D; Mieli-Vergani G World J Gastroenterol; 2008 Jun; 14(21):3306-12. PubMed ID: 18528928 [TBL] [Abstract][Full Text] [Related]
20. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I. Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]